Literature DB >> 2893942

Severe dapsone syndrome due to weekly maloprim.

M L Grayson, A P Yung, R R Doherty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893942     DOI： 10.1016/s0140-6736(88)91321-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Idiosyncratic reaction resembling toxic epidermal necrolysis caused by chloroquine and maloprim.

Authors:  P A Phillips-Howard; J Warwick Buckler
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

3.  Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Authors:  M Keuter; A van Eijk; M Hoogstrate; M Raasveld; M van de Ree; W A Ngwawe; W M Watkins; J B Were; A D Brandling-Bennett
Journal:  BMJ       Date:  1990-09-08

Review 4.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.